Cannabis in Israel

Legal Status Overview

Israel occupies a distinctive position in global cannabis policy: it is simultaneously one of the world's most advanced medical cannabis jurisdictions and a country where recreational use exists in a decriminalized grey zone. The country has been at the forefront of cannabis research since the early 1960s, when Professor Raphael Mechoulam — widely considered the "father of cannabis research" — first isolated and synthesized THC at the Hebrew University of Jerusalem.

The recreational cannabis framework is governed by a 2017 government decision that effectively decriminalized personal possession, removing criminal prosecution as a consequence for first and second offenses. Under this framework, adults found with small amounts of cannabis receive a civil fine rather than criminal charges. This is not full legalization — cannabis purchase and sale remain illegal, and there is no regulated supply chain for recreational users. But the practical enforcement reality for personal use has shifted significantly.

Israel's Knesset has debated multiple full legalization bills. The coalition government under Prime Minister Bennett advanced a legalization proposal in 2021 that passed committee stages, but the collapse of the coalition before the bill reached a final vote prevented implementation. Subsequent governments have included cannabis legalization in coalition agreement negotiations, but the political instability that has characterized Israeli governance in recent years has repeatedly delayed final passage.

The country's complex political environment — with coalition governments involving religious parties who oppose legalization, security-focused parties with mixed positions, and liberal parties pushing reform — means that cannabis legalization has been consistently on the agenda while remaining elusive in practice. The trajectory is clearly toward full legalization, but timing remains uncertain.

Israel has a relatively young, internationally oriented population with high cannabis use rates. Tel Aviv in particular has developed a vibrant cannabis culture, with widespread use in parks, beaches, and social settings. The decriminalization framework reflects and accommodates this reality without fully legalizing the market.

Possession Laws & Penalties

Israel's decriminalization framework, established through a 2017 government decision and implemented through police enforcement guidelines, creates a tiered administrative response to cannabis possession.

The decriminalization framework applies to Israeli citizens and legally present foreigners alike. Tourists found with small amounts of cannabis are subject to the same NIS 1,000 fine system. However, a tourist's first offense in Israel is technically their first recorded offense in the Israeli system — not their first offense globally. Enforcement at airports remains separate from the urban decriminalization policy, and travelers should not attempt to bring cannabis through Ben Gurion Airport's security systems.

Police discretion plays a significant role. While the official framework is administrative fines, individual officers have broad latitude in determining how a situation is handled. In some areas and circumstances, possession encounters are resolved with a warning or informal interaction. In other contexts — particularly near protests, political events, or in areas with high crime — officers may apply stricter standards.

Medical Cannabis Program

Israel's medical cannabis program is among the most sophisticated in the world. The program began in 1992 when the government first authorized cannabis for compassionate use by a small number of patients. Under the influence of Professor Mechoulam's ongoing research at Hebrew University, the program expanded progressively over the following decades.

The current regulatory framework is overseen by the Israeli Medical Cannabis (IMC) regulatory unit within the Ministry of Health. The IMC licenses cultivators, processors, distributors, and dispensary operators. Medical cannabis is prescribed by licensed physicians for qualifying conditions and dispensed through a network of licensed pharmacies and specialized dispensaries.

Israel's medical cannabis industry has become a global export powerhouse. The government authorized medical cannabis exports in 2019, and Israeli companies — leveraging decades of research expertise, advanced greenhouse cultivation technology, and a strong biotech ecosystem — have become major international suppliers. Israeli medical cannabis is exported to Germany, the United Kingdom, Australia, Canada, and numerous other markets.

Qualifying conditions for medical cannabis in Israel are broad and include:

Chronic pain; neuropathic pain; cancer pain and cancer-related symptoms; post-traumatic stress disorder (PTSD) — Israel has been a pioneer in using cannabis for PTSD treatment, with significant populations of military veterans and trauma survivors included in the patient base; multiple sclerosis; inflammatory bowel disease; autism spectrum disorder; epilepsy; Parkinson's disease; and palliative care applications. Israel has been particularly forward-leaning on PTSD treatment with cannabis, with research programs at multiple Israeli universities.

The patient population receiving medical cannabis in Israel has grown to include hundreds of thousands of licensed patients. The dispensary infrastructure is well-developed, with dozens of licensed dispensaries across the country offering a range of cannabis products including flower, oils, capsules, and vaporizer products.

Cultivation Laws

Cannabis cultivation in Israel requires a license from the Ministry of Health. Unlicensed cultivation is illegal regardless of scale. There is no home cultivation provision for recreational users — the decriminalization framework covers possession but not growing.

Licensed cultivation for medical purposes operates under strict IMC regulatory oversight. Cultivation licenses are issued to companies meeting security, quality, and operational standards. Licensed cultivators operate large-scale greenhouse and indoor facilities, producing both Israeli domestic supply and export-quality product for international markets.

The Israeli agricultural sector has applied its advanced drip irrigation, climate control, and precision agriculture expertise to cannabis cultivation, producing strains with high cannabinoid content and rigorous quality testing standards. Israeli genetics — including varieties developed through decades of research and selective breeding — are highly regarded in international cannabis markets.

Research cultivation — for academic and scientific purposes — requires separate authorization through the Ministry of Health's research licensing framework. Hebrew University, Tel Aviv University, the Weizmann Institute, and other Israeli research institutions conduct extensive cannabinoid research under research licenses.

Industrial hemp cultivation (low-THC cannabis for fiber and seed) operates under a separate licensing framework administered by the Ministry of Agriculture. Israeli farmers have shown interest in hemp as an agricultural crop, and the regulatory framework has evolved to accommodate this.

Trafficking Penalties

Drug trafficking in Israel remains a serious criminal offense with significant prison terms. The decriminalization of personal use has not affected the treatment of supply-side cannabis offenses.

Israeli courts have historically applied firm sentences for drug trafficking, reflecting a dual standard: tolerance for personal use alongside serious enforcement against supply chains. This is consistent with a harm-reduction philosophy — the user is not criminalized, but those who profit from supplying the illicit market are treated as criminals.

Cannabis Culture & History

Israel's cannabis culture is deeply influenced by the country's diverse immigrant population, its proximity to cannabis-producing regions in Lebanon (Lebanese hash has been legendary since the 1960s), and the unique social environment of a young state with a significant military culture and associated trauma burden.

Cannabis arrived in pre-state Israel through multiple cultural streams: Arab communities in the region had traditions of hashish use extending back centuries; Jewish immigrants from North Africa and the Middle East brought cultural familiarity with cannabis; and the international counterculture movements of the 1960s–70s resonated strongly in the vibrant youth culture of Tel Aviv.

The military context is significant. Israel has universal military service, and its military has fought multiple major conflicts. The mental health burden on veterans — including high rates of PTSD — has created significant patient demand for cannabis-based treatments. The medical cannabis program's inclusion of PTSD as a qualifying condition reflects this reality and has been influential in shaping similar policy developments in the United States and elsewhere.

Tel Aviv has developed one of the most open cannabis cultures in the Middle East. Park use, beach use, and café-adjacent use are common, particularly in the younger demographic. The Florentin and Florentin neighborhoods, Levinsky Park, and the beaches along the Mediterranean are areas where cannabis use is visible and largely tolerated.

Israeli cannabis science has produced some of the world's most significant cannabinoid research, from Mechoulam's THC isolation in 1964 to the discovery of the endocannabinoid system, to contemporary research on CBD, CBG, and novel cannabinoids. The country's research tradition has given the medical program a scientific credibility that other national programs have struggled to match.

Travel Safety Guide

Israel represents a low-to-medium risk destination for cannabis-aware travelers. The decriminalization framework means that personal possession is not a criminal matter in most circumstances, but important caveats apply.

Ben Gurion Airport: The airport is one of the most security-intensive in the world due to Israel's security situation. Security staff at Ben Gurion are trained to detect a wide range of threats, and drug detection is part of their mandate. Do not carry cannabis through Ben Gurion Airport in any direction. Airport security operates independently of the urban decriminalization policy.

Tel Aviv vs. Jerusalem: Tel Aviv is significantly more tolerant of cannabis use than Jerusalem. Jerusalem, as a center of religious significance for three major religions, has more conservative social norms and more active enforcement in some areas. The Old City and religious neighborhoods such as Mea Shearim are particularly inappropriate places for cannabis use.

Tourist areas: In popular Tel Aviv areas such as the beach, the port, and the central city, cannabis use is common and enforcement is limited. However, the formal right to fine still exists, and police can and do issue fines.

Gaza Strip / West Bank border areas: Do not carry cannabis in or near military zones, checkpoints, or border areas. Soldiers at checkpoints operate under different rules than urban police and may treat cannabis possession differently.

Rental cars and driving: Driving under the influence of cannabis is illegal and enforced. Roadside drug tests are conducted in Israel. Do not drive after consuming cannabis.

Medical patients: Foreign medical cannabis patients should not bring their home-country medical cannabis into Israel. Israeli law does not recognize foreign medical cannabis prescriptions as authorizing importation. Leave medical cannabis products at home and consult an Israeli physician if treatment is needed during your visit.

Recent Legal Developments

Israel's cannabis policy has been in continuous evolution, with legalization appearing repeatedly in coalition negotiations and parliamentary debates. Key recent developments:

Full legalization legislation progress: Multiple legalization bills have advanced through Knesset committees in recent years. The most substantive was the 2021 proposal under the Bennett government, which included a regulated retail market with licensed stores, age verification, and taxation. Coalition collapse prevented final passage. Subsequent governments have included cannabis in coalition negotiations, and legalization remains a near-term likelihood.

Medical cannabis export expansion: Israel has progressively expanded its medical cannabis export authorizations. Israeli companies are now among the top suppliers to European medical cannabis markets, and bilateral export agreements have been signed with multiple countries.

IMC regulatory reform: The IMC has continuously updated its cultivation, processing, and distribution regulations to reflect growing industry scale and international best practices. Track-and-trace systems, laboratory testing standards, and dispensary operating requirements have all been enhanced.

CBD market development: Israel has developed an active CBD product market, with dozens of brands selling oils, cosmetics, and functional food products. Regulatory clarity around CBD products has improved, and the Israeli CBD market is now one of the more developed in the Middle East-Europe interface.

Research breakthroughs: Israeli research institutions continue to produce significant cannabinoid science. Ongoing research into rare cannabinoids (CBG, CBDA, THCV) and novel delivery methods positions Israel as a continued leader in cannabis pharmaceutical development.

Frequently Asked Questions